Tarui Disease (GSD VII) Exercise Tolerance Assessment

Assesses GSD type VII (phosphofructokinase deficiency / Tarui disease) using exercise intolerance score, hemolytic anemia severity (indirect bilirubin, reticulocyte count), and muscle CK during exertion.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Assesses GSD type VII (phosphofructokinase deficiency / Tarui disease) using exercise intolerance score, hemolytic anemia severity (indirect bilirubin, reticulocyte count), and muscle CK during exertion

Each component has a specific meaning:

  • Hemolytic anemia severity (indirect bilirubin — The hemolytic anemia severity (indirect bilirubin recorded for the scenario being assessed.
  • Reticulocyte count) — The reticulocyte count) recorded for the scenario being assessed.
  • Muscle CK during exertion — The muscle ck during exertion recorded for the scenario being assessed.

Note: Interpret the tarui gsd vii result against the thresholds and context described above.

How to Use

Enter the hemolytic anemia severity (indirect bilirubin, reticulocyte count), muscle CK during exertion for the scenario you are assessing. Assesses GSD type VII (phosphofructokinase deficiency / Tarui disease) using exercise intolerance score, hemolytic anemia severity (indirect bilirubin, reticulocyte count), and muscle CK during exertion. Use the tarui gsd vii result to inform your calculation.

Frequently Asked Questions